 Plasma Collection Station and Lot Release Volume of Blood Products of Major Comp
|
|
|
Revenue of China Major CRO Enterprises, 2014
|
|
|
Major Enterprises of China Enzyme Preparation Industry, 2014
|
|
|
Competition Structure ( by lot release quantity) of Some Extra EPI Vaccines in C
|
|
|
Main Enterprises of China Vacuum Blood Collection Industry and Their Vacuum Bloo
|
|
|
Capacity and Number of Pharmaceutical Excipients Species of Major Pharmaceutical
|
|
|
Recombinant Protein Drug Market Competition of Sample Hospitals in China (by Pro
|
|
|
Capacity of Major Heparin API Companies in China, as of June 2014
|
|
|
Time to Market and Annual Sales of Major Monoclonal Antibody Agents around the G
|
|
|
Global Major M&A Cases in DNA Sequencing Industry, 2007-2014
|
|
|
Infographic: Global and China Major Stem Cell Companies and Their Stem Cell Busi
|
|
|
Number of Single Plasma Collection Station and Revenue and Leading Blood Product
|
|
|
Animal Vaccine Sales of Main Vaccine Enterprises in China, 2013
|
|
|
Revenue and Net Income of Global and China Major CRO Enterprises, 2013 (Unit: US
|
|
|
Global Biodegradable Plastics Capacity by Manufacturers, 2013
|
|
|
Leading Enzyme Manufacturers in China
|
|
|
Novartis to shutter R&D site in June as global reorganization unfolds
|
|
|
Eli Lilly and Company (LLY) To Buy German Poultry Vaccine Maker For Undisclosed
|
|
|
Novartis AG (NVS)'s Potential Blockbuster Serelax Suffers Huge Setback
|
|
|
Santaris Pharma A/S, Roche (RHHBY) Strike $148 Million+ Alliance To Design And D
|
|
|
GE Healthcare Pads Its Life Sciences Division With $1.06 Billion Thermo Fisher S
|
|
|
Hepalink to acquire Scientific Protein Laboratories, Inc. with $337.5 Million Ca
|
|
|
Techpool Bio-pharma Co. is to cooperate with Takeda after successful experience
|
|
|
Neptunus to build Jiangsu Healthcare Products base with RMB 237mln
|
|
|
Thru 3Q 2013, both importation and exportation of bio-med kept increasing
|
|
|
Wanzhou District to strenghen its bio-tech competence with RMB 3 billion
|
|
|
Tofflon acquired 2 medical device companies to extend its biomedical products
|
|
|
Tsinghua University proved Hsp90α as the biomark for tumors for the first time
|
|
|
Johnson & Johnson(JNJ) is to invest $300 million in XiAn China to build manufact
|
|
|
The exportation of China's Vitamin industry decreased in 2013Q3
|
|
|
Lilly to pump in $350 million in China to boost insulin making capacity
|
|
|
Merck Serono announced commercialization agreement with BeiGene Co of China
|
|
|
Roche signed an R&D agreement on cancer research worth $1 billion
|
|
|
Dendreon to cut 150 jobs as cancer vaccine sales drop again
|
|
|
China enters global vaccine marketplace with one already been approved by WHO
|
|
|
Chinese Healthcare Spending
|
|
|
Corporate VC Investment in Healthcare
|
|
|
Sales Value of Major Monoclonal Antibody Agents Worldwide, 2012
|
|
|
Comparison on Number of Approved Drug Registration in China, 2006-2011
|
|
|
Total Diagnosed and Treated Population of Chinese Medical Institutions, 2010-201
|
|
 Monthly Revenue of Industry for Biochemical and Biological Products, Feb. 2008 -
|
|
|
Monthly Number of Enterprise for Biochemical and Biological Products, Feb. 2008
|
|
|
China Gets WHO Collaborating Center for Biological Products
|
|
|
Weekly Lot Release Volume of 23 Valence PPSV (0.5ml/bottle) (SANOFI PASTEUR), Ap
|
|
|
Weekly Lot Release Volume of 23 Valence PPSV (0.5ml/bottle) (Merck), Mar. 31, 20
|
|
|
China Bio-Med (HKG:8158) FY12 NL widens to $57M; no div
|
|
|
CK Life Sciences (HKG:0775) 1H net profit $115.6M, up 40%; no div
|
|
|
China Grand Pharm (HKG:0512) to boost stocks in GPCCL to 91.1%
|
|
|
NT Pharma (HKG:1011) suspended for price-sensitive ann
|
|
|
CGN Mining (HKG:1164): exch bond issued to Silver Grant (HKG:0171)
|
|
|